Citadel Advisors »

Kiora Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Kiora Pharmaceuticals (KPRX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Kiora Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kiora Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kiora Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $125k 45k 2.80
2025-03-31 $80k 27k 3.01
2024-09-30 $37k 10k 3.66

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Spdr Gold Tr Gold Shs Call Option (GLD)
Ishares Tr Russell 2000 Etf (IWM)
Amazon Call Option (AMZN)
Strategy Cl A New Call Option (MSTR)
Alphabet Cap Stk Cl A Call Option (GOOGL)
UnitedHealth Call Option (UNH)
Palantir Technologies Cl A Call Option (PLTR)
Netflix Call Option (NFLX)

View all positions for Citadel Advisors

Top funds holding Kiora Pharmaceuticals

ADAR1 Capital Management
Nantahala Capital Management
Stonepine Capital Management
Citadel Advisors
DRW Holdings
Vanguard Group
Geode Capital Management
Renaissance Technologies
Two Sigma Investments
UBS Group
SBI Securities
BlackRock
Goss Wealth Management
Activest Wealth Management
Advisor Group Holdings

View all funds holding Kiora Pharmaceuticals